Award Expands Ducommun’s Content on A320neo
LOS ANGELES, Jan. 25, 2017 -- Ducommun Incorporated (NYSE:DCO) (“Ducommun” or the “Company”) today announced it has received a multiyear, multimillion dollar contract from Airbus to produce additional titanium structures for engine support and engine frames on the A320neo (new engine option) aircraft. The award increases Ducommun’s content on the single-aisle jetliner. Ducommun will manufacture these titanium engine support structures using its proprietary hot forming and super-plastic forming processes at its operations center in Parsons, Kan.
“This award further demonstrates our support of Airbus with innovative, value-added structural solutions, and we are certainly pleased to see their continued confidence in our capabilities,” said Stephen G. Oswald, president and chief executive officer. “We believe our expertise in a wide array of titanium forming technologies presents numerous opportunities for accelerated growth across the aerospace industry. This is a key area of strategic focus for Ducommun, and we are investing in technologies that will support our customers’ changing requirements for their next generation aircraft.”
For more information about the Airbus A320neo, visit
http://www.airbus.com/aircraftfamilies/passengeraircraft/a320family/spotlight-on-a320neo/.
About Ducommun Incorporated
Ducommun Incorporated delivers innovative, value-added manufacturing solutions to customers in the aerospace, defense and industrial markets. Founded in 1849, the company specializes in two core areas – Electronic Systems and Structural Systems – to produce complex products and components for commercial aircraft platforms, mission-critical military and space programs, and sophisticated industrial applications. For more information, visit www.ducommun.com.
Statements contained in this press release regarding other than recitation of historical facts are forward-looking statements. These statements are identified by words such as “may,” “will,” “ begin,” “ look forward,” “expect,” “believe,” “intend,” “anticipate,” “should”, “potential,” “estimate,” “continue,” “momentum” and other words referring to events to occur in the future. These statements reflect the Company’s current view of future events and are based on its assessment of, and are subject to, a variety of risks and uncertainties beyond its control, including, but not limited to, the state of the world financial, credit, commodities and stock markets, and uncertainties regarding the Company, its businesses and the industries in which it operates, which are described in the Company’s filings with the Securities and Exchange Commission. The Company is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise.
CONTACTS: Douglas L. Groves, Vice President, Chief Financial Officer and Treasurer, 310.513.7200 Chris Witty, Investor Relations, 646.438.9385, [email protected]


California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Italy Fines Apple €98.6 Million Over App Store Dominance
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 



